All In MedTech

Device Trial Radar · NCT03791489

Multi-Treatment PNN Modulation for Chronic Rhinitis

Feasibility Study of Multi-Treatment Posterior Nasal Nerve (PNN) Modulation for Treatment of Chronic Rhinitis

Last checked: Nov 20, 2026Latest source record: Jul 24, 2020 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

30

Actual

Start

Dec 1, 2018

Primary completion

Jul 18, 2019

Study completion Jul 18, 2019

Sponsor

Lead sponsor
Arrinex, Inc.Not on our public-company list
Sponsor type
Industry
First posted
Jan 2, 2019

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Feasibility of treatment at multiple sites with the ClariFix cryoablation device for treatment of chronic rhinitis

Conditions

  • Chronic Rhinitis

Interventions

  • ClariFixDevice

    The ClariFix™ device (K162608) is an FDA 510(k) cleared Class II cryosurgical tool indicated for the destruction of unwanted tissue during surgical procedures, including in adults with chronic rhinitis.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Participants With Procedure-related Serious Adverse Events (SAEs) and/or Serious Adverse Device Effects (SADE)Time frame: Study duration (90-days)

Locations

3 sites in 1 country. Site status is shown where the registry gives one.

  • San Francisco Otolaryngology Medical Group

    San Francisco, California

  • Bethlehem ENT

    Bethlehem, Pennsylvania

  • Tracy Byerly, MD

    Fredericksburg, Texas

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.